Joshua WangFounder & CEO at VerImmunePresenter
Profile
PhD-trained at Johns Hopkins School of Medicine in drug delivery/vaccine platforms. Previously raised ~$16.5M and secured partnerships with Janssen Biologics and Fosun Pharmaceuticals. Prior to VerImmune, Flagship Pioneering and contributed to the spin-out Ring Therapeutics.
